Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.

de Lange M, Cohn DM, Gobert D, Riedl MA, Zanichelli A, Brewer K, Clifford S, Pattanaik S, Romero B, Chen M, Mendivil J

Open source

DOI
10.3389/fimmu.2026.1810851
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1810851,
  title = {Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.},
  author = {de Lange M and Cohn DM and Gobert D and Riedl MA and Zanichelli A and Brewer K and Clifford S and Pattanaik S and Romero B and Chen M and Mendivil J},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1810851},
  url = {https://doi.org/10.3389/fimmu.2026.1810851}
}

RIS

TY  - JOUR
TI  - Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.
AU  - de Lange M
AU  - Cohn DM
AU  - Gobert D
AU  - Riedl MA
AU  - Zanichelli A
AU  - Brewer K
AU  - Clifford S
AU  - Pattanaik S
AU  - Romero B
AU  - Chen M
AU  - Mendivil J
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1810851
UR  - https://doi.org/10.3389/fimmu.2026.1810851
ER  - 

APA

M, D. L., DM, C., D, G., MA, R., A, Z., K, B., S, C., S, P., B, R., M, C., & J, M. (2026). Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1810851

Source records